Treatment of heart failure with spironolactone--trial and tribulations.
McMurray
John J V
JJ
Department of Cardiology, Western Infirmary, Glasgow, Scotland, United Kingdom.
O'Meara
Eileen
E
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology / Q000627:therapeutic use; D000375:Aging / Q000502:physiology; D000450:Aldosterone / Q000096:biosynthesis; D004359:Drug Therapy, Combination; D005919:Glomerular Filtration Rate; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D006947:Hyperkalemia / Q000139:chemically induced*; D007668:Kidney / Q000502:physiology; D000451:Mineralocorticoid Receptor Antagonists / Q000008:administration & dosage / Q000009:adverse effects*; D013148:Spironolactone / Q000008:administration & dosage / Q000009:adverse effects*
D000319:Adrenergic beta-Antagonists; D000451:Mineralocorticoid Receptor Antagonists; D013148:Spironolactone; D000450:Aldosterone